Endophenotypes for Age-Related Macular Degeneration: Extending Our Reach into the Preclinical Stages of Disease

The key to reducing the individual and societal burden of age-related macular degeneration (AMD)-related vision loss, is to be able to initiate therapies that slow or halt the progression at a point that will yield the maximum benefit while minimizing personal risk and cost. There is a critical need...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorin, Michael B., Weeks, Daniel E., Baron, Robert V., Conley, Yvette P., Ortube, Maria C., Nusinowitz, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284143/
https://www.ncbi.nlm.nih.gov/pubmed/25568804
http://dx.doi.org/10.3390/jcm3041335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284143/
https://www.ncbi.nlm.nih.gov/pubmed/25568804
http://dx.doi.org/10.3390/jcm3041335

Ejemplares similares